These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9185505)

  • 1. Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.
    Dibbern DA; Glazner GW; Gozes I; Brenneman DE; Hill JM
    J Clin Invest; 1997 Jun; 99(12):2837-41. PubMed ID: 9185505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity-dependent neurotrophic factor: a potent regulator of embryonic growth and development.
    Glazner GW; Gressens P; Lee SJ; Gibney G; Gozes I; Gozes Y; Brenneman DE; Hill JM
    Anat Embryol (Berl); 1999 Jul; 200(1):65-71. PubMed ID: 10395007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
    Gressens P; Marret S; Hill JM; Brenneman DE; Gozes I; Fridkin M; Evrard P
    J Clin Invest; 1997 Jul; 100(2):390-7. PubMed ID: 9218516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-I as a mediator of VIP/activity-dependent neurotrophic factor-stimulated embryonic growth.
    Servoss SJ; Lee SJ; Gibney G; Gozes I; Brenneman DE; Hill JM
    Endocrinology; 2001 Aug; 142(8):3348-53. PubMed ID: 11459777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
    Zusev M; Gozes I
    Regul Pept; 2004 Dec; 123(1-3):33-41. PubMed ID: 15518891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.
    Brenneman DE; Westbrook GL; Fitzgerald SP; Ennist DL; Elkins KL; Ruff MR; Pert CB
    Nature; 1988 Oct; 335(6191):639-42. PubMed ID: 2845276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide regulates embryonic growth through the action of activity-dependent neurotrophic factor.
    Hill JM; Glazner GW; Lee SJ; Gozes I; Gressens P; Brenneman DE
    Ann N Y Acad Sci; 1999; 897():92-100. PubMed ID: 10676438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse.
    Gressens P; Hill JM; Paindaveine B; Gozes I; Fridkin M; Brenneman DE
    J Clin Invest; 1994 Nov; 94(5):2020-7. PubMed ID: 7962548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32.
    Vaudry D; Gonzalez BJ; Basille M; Pamantung TF; Fontaine M; Fournier A; Vaudry H
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13390-5. PubMed ID: 11087878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
    Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
    Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A femtomolar-acting neuroprotective peptide.
    Brenneman DE; Gozes I
    J Clin Invest; 1996 May; 97(10):2299-307. PubMed ID: 8636410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos.
    Gressens P; Hill JM; Gozes I; Fridkin M; Brenneman DE
    Nature; 1993 Mar; 362(6416):155-8. PubMed ID: 8383805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein down-regulation of neuronal pituitary adenylate cyclase-activating polypeptide and reciprocal effects on vasoactive intestinal peptide expression.
    Pavelock KA; Girard BM; Schutz KC; Braas KM; May V
    J Neurochem; 2007 Feb; 100(3):603-16. PubMed ID: 17181550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death.
    Nosheny RL; Bachis A; Acquas E; Mocchetti I
    Eur J Neurosci; 2004 Dec; 20(11):2857-64. PubMed ID: 15579139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity.
    Brenneman DE; Hauser JM; Spong C; Phillips TM
    Neuropeptides; 2002 Aug; 36(4):271-80. PubMed ID: 12372701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.
    Nakata M; Kohno D; Shintani N; Nemoto Y; Hashimoto H; Baba A; Yada T
    Neurosci Lett; 2004 Nov; 370(2-3):252-6. PubMed ID: 15488333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system.
    Mocchetti I; Nosheny RL; Tanda G; Ren K; Meyer EM
    Ann N Y Acad Sci; 2007 Dec; 1122():144-54. PubMed ID: 18077570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.